1-3 of 3
David Qualls
Close
Sort by
Journal Articles

Retrospective characterization of nodal marginal zone lymphoma

Robert Stuver, Esther Drill, David Qualls, Michelle Okwali, Connie Lee Batlevi, Philip C. Caron, Ahmet Dogan, Zachary D. Epstein-Peterson, Lorenzo Falchi, Paul A. Hamlin, Steven M. Horwitz, Brandon S. Imber, Andrew M. Intlekofer, William T. Johnson, Niloufer Khan, Anita Kumar, Oscar B. Lahoud, Jennifer Kimberly Lue, Matthew J. Matasar, Alison J. Moskowitz, Ariela Noy, Colette N. Owens, M. Lia Palomba, Heiko Schöder, Santosha A. Vardhana, Joachim Yahalom, Andrew D. Zelenetz, Gilles Salles, David J. Straus
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4838–4847.
https://doi.org/10.1182/bloodadvances.2022009587
Published: 2023
Includes: Supplemental data
Journal Articles

Comorbidities in DLBCL: too "Severe4" CAR-T therapy?

David Qualls, Caron A. Jacobson
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3469–3471.
https://doi.org/10.1182/bloodadvances.2023009834
Published: 2023
Journal Articles

A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma

Clinical Trials & Observations
David Qualls, Hiu Ying Lam, Karissa Whiting, Anita Kumar, Matthew Matasar, Colette Owens, Chelsea Nichols, James A Espeleta, Annie Qiu, Sarima Subzwari, Erin Biggar, Venkatraman Seshan, Gilles Salles, Anas Younes, Connie Batlevi
Journal: Blood Advances
Blood Adv (2022) 6 (18): 5262–5266.
https://doi.org/10.1182/bloodadvances.2021006555
Published: 2022
Includes: Supplemental data